Target intelligence / Profile preview

Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1)

Target
TgCDPK1
Molecular classification
Enzyme, Kinase, Serine/threonine protein kinase, Calcium-dependent protein kinase
01

Overview

Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1) is a vital enzyme that regulates the essential life cycle stages of the protozoan parasite Toxoplasma gondii (UniProt Q9BJF5). It acts as a primary calcium sensor, translating intracellular calcium fluxes into the activation of gliding motility, microneme secretion, and host cell invasion and egress (Lourido et al., 2010, Nature). Because TgCDPK1 is essential for parasite survival and lacks a direct ortholog in humans, it is a highly attractive therapeutic target for treating toxoplasmosis (Sugi et al., 2010, JBC). A defining structural feature of TgCDPK1 is its small glycine gatekeeper residue (G128) in the ATP-binding pocket, which is absent in nearly all human kinases. This structural difference allows for the development of selective 'Bumped Kinase Inhibitors' (BKIs) that can potently inhibit the parasite enzyme while sparing human kinases, thereby reducing potential toxicity (Ojo et al., 2010, J Med Chem).

Other names
CDPK1Calcium-dependent protein kinase 1TgCDPK1
02

Mechanism of action

Inhibition of kinase activity by binding to the ATP-binding pocket, specifically exploiting the unique small gatekeeper residue (Glycine 128) to achieve selectivity over human kinases.

03

Biological functions

Parasite invasionParasite egressGliding motilityMicroneme secretionSignal transductionCalcium signaling
04

Disease associations

InfectionToxoplasmosis
05

Safety considerations

Selectivity over human Src-family kinasesPotential for resistance mutations at the gatekeeper residueEmbryo-fetal toxicity (observed with some BKI analogs)
06

Interacting drugs

BKI-1294

4 more in the full profile.

07

Biomarkers

Parasite DNA loadTgCDPK1 G128 gatekeeper mutation status

Beyond the preview

Go deeper on Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call